Victoria Vakiener - Chief Commercial Officer, Epizyme, Inc

As of February 5, 2021


Victoria Vakiener Net Worth

  • Net worth is estimated to be at least $217.78K
  • Owns at least 52,685 units of Epizyme, Inc stock
  • Sold an estimated value of $15.99K recently at Epizyme, Inc

Victoria Vakiener Trading

  • Largest sale of shares was 817 units , worth over $9.16K on February 5, 2021
  • In total has made about 3 transactions recently
  • Usually trades in February, with the busiest year in 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Victoria Vakiener Mailing Address

  • Mailing address is C/o Epizyme, Inc. 400 Technology Square Cambridge MA 02139 MA

Epizyme, Inc Executive Compensation

Name
Year
Salary
Bonus
Restricted Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Robert B. Bazemore Jr. 2020 $650,000 - $3,237,620 $4,103,853 $370,500 $96,369 $8,458,342
Robert B. Bazemore Jr. 2019 $592,937 - $1,105,393 $2,060,531 $409,127 $5,630 $4,173,618
Robert B. Bazemore Jr. 2018 $575,667 - - $2,748,939 $320,575 $5,690 $3,650,871
Paolo Tombesi 2020 $460,000 - $250,006 $750,730 $174,800 $48,198 $1,683,734
Paolo Tombesi 2019 $168,901 - $612,848 $1,173,669 $76,076 $146,971 $2,178,465
Matthew E. Ros 2020 $447,982 - $250,006 $750,730 $174,800 $11,271 $1,634,789
Matthew E. Ros 2019 $432,600 - $538,793 $899,137 $199,861 $11,598 $2,081,989
Matthew E. Ros 2018 $420,000 - - $1,099,576 $187,100 $12,214 $1,718,890
Dr. Shefali Agarwal 2020 $478,000 - $274,990 $825,799 $199,804 $7,154 $1,785,747
Dr. Shefali Agarwal 2019 $463,500 - $894,607 $1,255,325 $265,122 $8,652 $2,887,206
Dr. Shefali Agarwal 2018 $199,615 $125,000 - $1,472,846 $200,500 $1,648 $1,999,609
Jeffery L. Kutok, M.D., Ph.D. 2020 $337,500 $85,000 $374,996 $1,124,996 $134,663 $6,813 $2,063,968
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1571498/000119312521138283/d839557ddef14a.htm

Epizyme, Inc Insider Trading

  • The most recent transaction was 2,029 units sold on April 7, 2021 by Jeffery Kutok worth over $17.86K
  • In the last 8 years, insiders at Epizyme, Inc sold an estimated value of $153.26M and bought an estimated value of $343.63M
  • The most active traders are Robert Copeland, President Research and CSO,  David Mott, Director,  and Andrew Singer, EVP & CFO
  • Insider trading is most common in June, with the busiest year in 2014
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1